HLA-DRA and neoplasm: Further data analysis revealed that tumor cells co-expressing HLA-DRA and CD74 might activate T cells and induce PD-(L)1 expression, compared to HLA-DRA-negative tumor cells (Supplementary Fig. S2c), indicating a more frequent interaction between T cells and malignant cells in APHC than in ANHC.